Patti O’Brien

820 total citations
18 papers, 398 citations indexed

About

Patti O’Brien is a scholar working on Oncology, Cancer Research and Physiology. According to data from OpenAlex, Patti O’Brien has authored 18 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Cancer Research and 4 papers in Physiology. Recurrent topics in Patti O’Brien's work include Cancer survivorship and care (6 papers), Breast Cancer Treatment Studies (4 papers) and Nutrition and Health in Aging (4 papers). Patti O’Brien is often cited by papers focused on Cancer survivorship and care (6 papers), Breast Cancer Treatment Studies (4 papers) and Nutrition and Health in Aging (4 papers). Patti O’Brien collaborates with scholars based in Canada, Australia and United States. Patti O’Brien's co-authors include Mary Ann McColl, Marshall Godwin, S. E. D. Shortt, Catherine Donnelly, Kathleen I. Pritchard, Lois E. Shepherd, Mark N. Levine, Margot J. Burnell, Kathy S. Albain and Karen A. Gelmon and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Archives of Physical Medicine and Rehabilitation.

In The Last Decade

Patti O’Brien

15 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patti O’Brien Canada 8 160 111 79 54 45 18 398
Carol McPherson United States 9 222 1.4× 43 0.4× 191 2.4× 60 1.1× 20 0.4× 14 494
G. Sumo United Kingdom 5 361 2.3× 205 1.8× 106 1.3× 43 0.8× 60 1.3× 8 507
C. Louzado Canada 7 250 1.6× 32 0.3× 90 1.1× 50 0.9× 24 0.5× 11 442
Joshua R. Niska United States 10 65 0.4× 73 0.7× 80 1.0× 34 0.6× 24 0.5× 21 525
Nirav S. Kapadia United States 13 143 0.9× 69 0.6× 148 1.9× 42 0.8× 43 1.0× 45 463
Jessica I. Billig United States 14 134 0.8× 218 2.0× 25 0.3× 80 1.5× 30 0.7× 59 788
Raghid Charara Lebanon 8 233 1.5× 65 0.6× 83 1.1× 73 1.4× 17 0.4× 15 512
Rhodé M. Bijlsma Netherlands 13 197 1.2× 75 0.7× 60 0.8× 52 1.0× 25 0.6× 43 494
Katharina Hancke Germany 14 116 0.7× 133 1.2× 23 0.3× 41 0.8× 34 0.8× 48 807
Zeynep Özsaran Türkiye 13 156 1.0× 22 0.2× 58 0.7× 68 1.3× 32 0.7× 48 499

Countries citing papers authored by Patti O’Brien

Since Specialization
Citations

This map shows the geographic impact of Patti O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patti O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patti O’Brien more than expected).

Fields of papers citing papers by Patti O’Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patti O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patti O’Brien. The network helps show where Patti O’Brien may publish in the future.

Co-authorship network of co-authors of Patti O’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of Patti O’Brien. A scholar is included among the top collaborators of Patti O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patti O’Brien. Patti O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Spears, Melanie, Alister D’Costa, Bingshu E. Chen, et al.. (2016). A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial. Oncotarget. 7(31). 49099–49106. 2 indexed citations
3.
Courneya, Kerry S., Janette L. Vardy, Christopher J. O’Callaghan, et al.. (2016). Effects of a structured exercise program on physical activity and health-related fitness in colon cancer survivors: One year feasibility results from the NCIC CTG CO.21 (CHALLENGE) trial.. Journal of Clinical Oncology. 34(15_suppl). 3621–3621. 1 indexed citations
4.
Lohmann, Ana Elisa, Judy-Anne W. Chapman, Margot J. Burnell, et al.. (2015). Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer. Breast Cancer Research and Treatment. 150(3). 605–611. 15 indexed citations
5.
Trudeau, Maureen, Judith‐Anne W. Chapman, Baoqing Guo, et al.. (2015). A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22. SpringerPlus. 4(1). 631–631. 7 indexed citations
6.
Booth, Christopher M., Janette L. Vardy, Christopher J. O’Callaghan, et al.. (2015). A phase III study of the impact of a physical activity program on disease-free survival in patients with high-risk stage II or stage III colon cancer: A randomized controlled trial (NCIC CTG CO.21).. Journal of Clinical Oncology. 33(15_suppl). TPS3620–TPS3620. 1 indexed citations
7.
Liu, Shuzhen, Judy-Anne W. Chapman, Margot J. Burnell, et al.. (2014). Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial. Breast Cancer Research and Treatment. 149(2). 439–448. 37 indexed citations
8.
Cheung, Patrick, Sergio Faria, Shahida Ahmed, et al.. (2014). Phase II Study of Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy for Stage T1-3 N0 M0 Non-Small Cell Lung Cancer: NCIC CTG BR.25. JNCI Journal of the National Cancer Institute. 106(8). dju164–dju164. 57 indexed citations
9.
Booth, Christopher M., Janette L. Vardy, Sharlene Gill, et al.. (2014). A phase III study of the impact of a physical activity program on disease-free survival in patients with high-risk stage II or stage III colon cancer: A randomized controlled trial (NCIC CTG CO.21).. Journal of Clinical Oncology. 32(15_suppl). TPS3663–TPS3663. 1 indexed citations
10.
Lohmann, Ana Elisa, Judy‐Anne W. Chapman, Margot J. Burnell, et al.. (2014). Prognostic associations of 25OH vitamin D in NCIC CTG MA.21, a phase III adjuvant RCT of three chemotherapy regimens (EC/T, CEF, AC/T) in high-risk breast cancer (BC).. Journal of Clinical Oncology. 32(15_suppl). 504–504. 1 indexed citations
11.
Gelmon, Karen A., Judy‐Anne W. Chapman, Shuzhen Liu, et al.. (2014). Prognostic and predictive significance of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial.. Journal of Clinical Oncology. 32(15_suppl). 11019–11019. 1 indexed citations
12.
Courneya, Kerry S., Janette L. Vardy, Sharlene Gill, et al.. (2014). Update on the Colon Health and Life-Long Exercise Change Trial: A Phase III Study of the Impact of an Exercise Program on Disease-Free Survival in Colon Cancer Survivors. Current Colorectal Cancer Reports. 10(3). 321–328. 24 indexed citations
13.
Booth, Christopher M., Kerry S. Courneya, Janette L. Vardy, et al.. (2013). A phase III study of the impact of a physical activity program on disease-free survival in patients with high-risk stage II or stage III colon cancer: A randomized controlled trial (NCIC CTG CO.21).. Journal of Clinical Oncology. 31(15_suppl). TPS3647–TPS3647.
14.
O’Brien, Patti, et al.. (2010). CSI. Critical Care Nursing Quarterly. 33(2). 190–199. 18 indexed citations
15.
McColl, Mary Ann, et al.. (2009). Models for Integrating Rehabilitation and Primary Care: A Scoping Study. Archives of Physical Medicine and Rehabilitation. 90(9). 1523–1531. 107 indexed citations
16.
Parissenti, Amadeo M., Judy‐Anne W. Chapman, Harriette J. Kahn, et al.. (2009). Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients. Breast Cancer Research and Treatment. 119(2). 347–356. 13 indexed citations
17.
18.
O’Brien, Patti. (1970). An Informal Reading Inventory--A New Approach.. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carol McPherson Breakdown of academic impact, for papers by G. Sumo Breakdown of academic impact, for papers by C. Louzado Breakdown of academic impact, for papers by Joshua R. Niska Breakdown of academic impact, for papers by Nirav S. Kapadia Breakdown of academic impact, for papers by Jessica I. Billig Breakdown of academic impact, for papers by Raghid Charara Breakdown of academic impact, for papers by Rhodé M. Bijlsma Breakdown of academic impact, for papers by Katharina Hancke Breakdown of academic impact, for papers by Zeynep Özsaran
Rankless by CCL
2026